Ezewudo, Matthew
Borens, Amanda http://orcid.org/0000-0002-5695-3463
Chiner-Oms, Álvaro http://orcid.org/0000-0002-0463-0101
Miotto, Paolo http://orcid.org/0000-0003-4610-2427
Chindelevitch, Leonid
Starks, Angela M.
Hanna, Debra
Liwski, Richard
Zignol, Matteo
Gilpin, Christopher
Niemann, Stefan
Kohl, Thomas Andreas
Warren, Robin M.
Crook, Derrick
Gagneux, Sebastien
Hoffner, Sven http://orcid.org/0000-0002-3168-2863
Rodrigues, Camilla
Comas, Iñaki http://orcid.org/0000-0001-5504-9408
Engelthaler, David M.
Alland, David
Rigouts, Leen
Lange, Christoph
Dheda, Keertan
Hasan, Rumina
McNerney, Ruth http://orcid.org/0000-0003-0505-2291
Cirillo, Daniela M.
Schito, Marco
Rodwell, Timothy C.
Posey, James
Article History
Received: 6 June 2018
Accepted: 11 September 2018
First Online: 18 October 2018
Change Date: 21 February 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing Interests
: M. Schito, R. Liwski, A. Borens and M. Ezewudo reports grants from Bill & Melinda Gates Foundation, during the conduct of the study. Dr. D. Hanna reports grants from Bill & Melinda Gates Foundation, outside the submitted work. C. Lange reports personal fees from Chiesi, personal fees from Gilead, personal fees from Becton Dickinson, personal fees from Janssen, personal fees from Astra Zeneca, personal fees from Thermo Fisher Scientific, outside the submitted work. I. Comas reports personal fees from FIND Foundation for Innovative Diagnostics, within the scope of relevance to submitted work. D. Alland reports grants from Cepheid, other from Rutgers University Patent Pool, during the conduct of the study; In addition, D. Alland has a patent for primers and probes to detect drug resistance mutations issued. L. Rigouts reports other from FIND, during the conduct of the study. K. Dheda reports grants from FIND, grants and personal fees from ALERE, grants and personal fees from Oxford Immunotec, grants and personal fees from Cellestis (now Qiagen), grants from eNose Company, grants from Statens Serum Institut, grants and personal fees from bioMeriux, grants and personal fees from Cepheid, grants from Antrum Biotec, grants from Hain Lifescience, outside the submitted work; In addition, Dr. Dheda has a patent Characterization of novel TB-specific urinary biomarkers pending, a patent A smart mask for monitoring cough-related infectious diseases pending, and a patent device for diagnosing extrapulmonary tuberculosis (EPTB) issued. S. Niemann reports grants from German Center for Infection Research, during the conduct of the study and worked as consultant for FIND. T.C. Rodwell reports funding from NIH (NIAID) and FIND during the conduct of the study. Á. Chiner-Oms, P. Miotto, A.M. Starks, J. Posey, D. Crook, R.M. Warren, R. Hasan, M. Zignol, C. Gilpin, L. Chindelevitch, R. McNerney, D. Engelthaler, C. Rodrigues, S. Gagneux, D.M. Cirillo, S. Hoffner and T. A. Kohl have nothing to disclose.